#HappeningToday at 12 PM ET! Our President and CEO, Soren Mogelsvang, PhD will be presenting at the Virtual Investor #LunchBreak event!
Access the event here: bit.ly/3xZUTtr
#VirtualInvestor #chroniccough #neuropathicpain #migraine #hyperactivebladder
Exxel Pharma to Participate in the Virtual Investor Lunch Break: The Exxel Opportunity.
bit.ly/4a2rAna
#VirtualInvestor #chroniccough #neuropathicpain #migraine #hyperactivebladder
MALABAR ANGELS NETWORK VIRTUAL INVESTOR Start-Up MEET
Zoom Session
27' 7th May 2023 Saturday
Time: 7:00 PM To 8:00 PM (IST)
For more details: 8075 767 822
#virtualinvestor #startupmeet #startupmeet up #zoommeeting #zoommeeting s #startupideas #startuptips #startups #startupbusiness
Our CEO, John Climaco, provides a program overview at the recent Virtual Investor 2023 Companies to Watch Event. Access the full webcast replay here: bit.ly/3XnCgHl
Virtual Investor Co. $CNSP #VirtualInvestor #GlioblastomaMultiforme #GBM #Oncology
Our CEO, Greg Bosch, gives a brief corporate overview. Watch the full webcast replay here: bit.ly/3GesgJh
#VirtualInvestor #Cancer #Oncology #DisruptingCancersEnergy #pancsm #PancreaticCancer #OvarianCancer #ovca #gynca
Scott Fine, CEO of Cyclo Therapeutics, believes we have the potential to bring safe and effective treatments to those who are desperately waiting.
$CYTH Virtual Investor Co. #VirtualInvestor #NiemannPick #NPC1 #AlzheimersDisease #AlzheimersAwareness
#HappeningToday : Join us for our presentation at 12 PM ET! Access the event and register here: bit.ly/3Lurvje
#VirtualInvestor $CNSP Virtual Investor Co.
#SaveTheDate for our participation in the Virtual Investor #LunchBreak event! We look forward to seeing you there!
bit.ly/3xZUTtr
@Investorvirtual #VirtualInvestor #chroniccough #neuropathicpain #migraine #hyperactivebladder
CEO of Cyclo Therapeutics, Scott Fine, provides color on our development pipeline.
Watch the full video here: bit.ly/3IpShbg
$CYTH Virtual Investor Co. #VirtualInvestor #NiemannPick #NPC1 #AlzheimersDisease #AlzheimersAwareness
Our CEO, John Climaco, tells us why he believes CNS Pharmaceutical is a company to watch in 2023. Access the full video webcast replay here: bit.ly/3XnCgHl
Virtual Investor Co. $CNSP #VirtualInvestor #GlioblastomaMultiforme #GBM #Oncology
Our CEO, Anthony Japour, highlights iTolerance. Watch the full video webcast here: bit.ly/3WY22lu
#VirtualInvestor #DiabetesAwareness #RegenerativeCellTherapy #T1D
#HappeningTomorrow : Join us tomorrow, May 3, for our presentation at 12 PM ET! Access the event and register here: bit.ly/3Lurvje
#VirtualInvestor $CNSP Virtual Investor Co.
Listen to our CEO, Anthony Japour, discuss why he believes iTolerance is a company to watch in 2023. Watch the full video webcast here: bit.ly/3WY22lu
#VirtualInvestor #DiabetesAwareness #RegenerativeCellTherapy #T1D
Our CEO, John Climaco, shares his excitement for the future of the Company. Watch the full webcast replay here: bit.ly/3iBuCdm
$CNSP #VirtualInvestor #GlioblastomaMultiforme #GBM #Oncology
Our CEO, John Climaco, provides a brief corporate overview at the recent Virtual Investor 2023 Companies to watch Event.
bit.ly/3XnCgHl
$CNSP #VirtualInvestor #GlioblastomaMultiforme #GBM #Oncology
Our CEO, John Climaco, provides an update on recent events happening with the Company. Watch the full webcast replay here: bit.ly/3iBuCdm
$CNSP #VirtualInvestor #GlioblastomaMultiforme #GBM #Oncology
Our CEO, Walter Klemp, provides insight to the unique properties of Annamycin, a next generation anthracycline.
bit.ly/3GECJzh $MBRX Virtual Investor Co. #VirtualInvestor #Oncology